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Alexander Randall described eight decades ago a heterogeneous nucleation process at the
tip of the renal papillae giving birth to calcium oxalate stones. Kidney stones were for the
ﬁrst time described to originate from calcium phosphate plaques growing in the interstitial
tissue, breaking the urothelium and then promoting calcium oxalate crystal aggregation at
their contact. During the next decades, few studies were dedicated to these Randall’s
plaques but the increasing incidence of calcium oxalate kidney stones, the development of
endoscopic procedures allowing plaque visualization and series evidencing the high pro-
portion of calcium oxalate stones generated on these plaques renewed interest in Randall’s
plaque. Although some progress has been made during the past two decades, the origin of
Randall’s plaques, their composition, their role in kidney stone epidemic, their speciﬁc
afﬁnity for some crystalline phases, and their potential deleterious effects on kidney tis-
sues are among the challenges that lie ahead.
© 2014 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Initial descriptions by Alexander Randall and
contemporaries
Alexander Randall, an American urologist, proposed in
1936 a new theory relative to “The origin and growth of
renal calculi” [1,2]. Based upon extensive forensic studies
performed between 1935 and 1938, he observed, at the tip
of the renal papillae, lesions consisting of calcium phos-
phate and carbonate deposits accumulating in the kidney
interstitium. These lesions were initially interstitial but
their growth was likely to result in urothelium rupture and
formation of plaque in contact with urine. He observed
small kidney stones made of calcium oxalate in 65/1154
pairs of kidneys (2.8%). Overall, plaques were present intions Fonctionnelles
, 75020 Paris, France.
.fr (E. Letavernier).
ed by Elsevier Masson SAS.19.6% of kidneys [2]. He also observed that calcium oxalate
stones expelled by patients harboured in some cases a
depression due to papilla imprinting and calcium phos-
phate residues, involving thereby plaques as the origin of
stones (Fig. 1). Alexander Randall distinguished two ways
for stone initiation: on the one hand, calcium phosphate
deposits may form typical plaques in the renal interstitium
leading to urothelium rupture in some cases (papillary
lesion type 1); on the other hand, calcium phosphate plugs
may be generated in the collecting duct, at the outlet of the
tubule (papillary lesion type 2). In both scenarios, calcium
phosphate initiates further a calcium oxalate stone het-
erogeneous nucleation process.
Several authors were interested in kidney calciﬁcations
during the same period. Rosenow observed plaques in 22%
of 239 kidneys and Vermooten in 17.2% of Caucasian pa-
tients' kidneys [3,4]. The calciﬁcations were present in the
interstitium but not in the tubule lumen [5]. Anderson
found microscopic evidence for “calcareous” plaques orThis is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Typical monohydrate calcium oxalate stones (type Ia, brown struc-
tures) harbouring papillary umbilication and Randall’s plaque made of
apatite (white structures).
Fig. 2. Scanning electron microscopy of a Randall’s plaque at the stone
surface, showing tubular structure remnants.
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kidneys and 20 apparently normal autopsy kidneys [6]. He
postulated that the calcareous material would originate
from the high concentration of calcium and other ions in
the interstitium. Phagocytic cells would in turn absorb this
material and die, leading to the formation of calcareous
“droplets”.
Despite these seminal studies, Randall’s plaque gener-
ated limited interest during the second part of the 20th
century. One of the reasons underlying this loss of attention
was the discrepancy between the clinical peak stone age
and the peak of Randall’s plaque, assessed through forensic
studies, respectively, before and after the ﬁfth decade of life
in those days. Nevertheless, Cifuentes-Delatte et al. re-
ported in the eighties a typical umbilication in 142/500
stones, evidencing their papillary origin [7,8]. Eighty seven
stones were studied in detail: 63 of these stones exhibited
Randall’s plaque residues. Electron microscopy revealed
that 13 of these 63 plaques exhibited calciﬁed tubules,
demonstrating their intrapapillary origin (Fig. 2).
2. Renewed interest in Randall’s plaque and recent
advances
During the past two decades, interest in Randall’s pla-
que increased, probably as a result of two factors, thedevelopment of reno-ureteroscopy and a potential increase
in the incidence of Randall’s plaque related stones. First, the
development of new urological techniques allowed
detailed examination of renal cavities and the direct visu-
alization of Randall’s plaques. Low and Stoller reported in
1997 the presence of Randall’s plaques on one or more
papillae in 74% of 57 patients who underwent ureteroscopic
or percutaneous stone removal. In 7 patients who under-
went reno-ureteroscopy for conditions unrelated to kidney
stones, only 3 (43%) had papillary plaques [9]. In 2006,
Matlaga et al found that 91% of papillae in 23 patients with
idiopathic calcium oxalate nephrolithiasis contained pla-
ques [10]. They evidenced that calcium oxalate stones were
actually attached on Randall’s plaques. More recently,
Linnes et al. reported that 99% of renal stone formers had
Randall’s plaque on at least one papilla [11]. In France,
prevalence of Randall’s plaque seems lower: Olivier Traxer
found Randall’s plaques in 57% of 287 stone formers who
underwent ﬂexible uretero-renoscopy. Plaqueswere visible
in only 27% of 173 non-stone forming patients [12,13].
Another matter of interest is that Randall’s plaque-
related stone prevalence is likely to have increased during
the past decades. Calcium oxalate stones are nowadays the
main type of urolithiasis inwestern countries. Longitudinal
studies performed in USA, Europe or Japan [14e17] report
an increase in calcium oxalate stone prevalence during the
last few decades. The risk factors involved in calcium oxa-
late stone formation arewell documented: lowdiuresis and
imbalance in the diet resulting in hypercalciuria,
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longitudinal study taking into account Randall’s plaque
related stones. Nevertheless, in France, the proportion of
stones harbouring an umbilication and typical plaques was
found to be three times more frequent in recent years than
three decades ago, especially in young patients [20]. Chil-
dren may form calcium oxalate stones from Randall’s pla-
que [21]. Taking into account the increased proportion of
Randall’s plaque related stones and the increase in calcium
oxalate stone prevalence, it may be hypothesized that
Randall’s plaque-related stone prevalence may have
increased during the past decades.
A major contribution in the ﬁeld of Randall’s plaque
dedicated research has been made by Evan et al. in 2003
[22]. They took advantage of kidney biopsies performed in
renal stone formers during percutaneous nephrolithoto-
mies. These biopsies were performed in upper, middle and
lower poles of papillae. They observed Randall’s plaque at
the tip of the renal papillae in the subepithelial position
and characterized calcium-containing structure deposits
surrounding Henle’s loop. These deposits were identiﬁed
by infrared microspectroscopy to be made of apatite and
carbonate. Electron microscopy evidenced that they were
located in the basement membrane of Henle’s loop but not
in the cell cytoplasm. These observations suggest that
Randall’s plaque apatite droplets form in Henle’s loop thin
limb basement membrane, spread in the interstitium and
form plaques. By contrast, Evan et al. observed in patients
affected by enteric hyperoxaluria due to jejuno-ileal bypass
an initial crystallization site in collecting duct lumen,
distinct from Randall’s plaque, conﬁrming eighty years
later the observations made by Alexander Randall.
The mechanisms underlying the formation of carbon-
ated apatite deposits remain elusive. Asplin et al. have
hypothesized that calcium phosphate supersaturation in
the thin limb of Henle’s loop would promote calcium
phosphate particle precipitation [23]. Some particles
attached to epithelial cells may actually undergo an endo-
cytosis process and precipitate in basement membranes
[24]. The precipitation would be favoured by the presence
of collagen and mucopolysaccharides. Once initiated, the
interstitial calciﬁcation process would extend in the inter-
stitium, forming plaques made of carbonated apatite at the
contact of macromolecules such as osteopontin [25].
3. Unsolved questions and future challenges
3.1. Randall’s plaque epidemiology: does Randall’s plaque-
related stone incidence increase?
Several longitudinal studies performed in western
countries have shown that calcium oxalate stones are more
and more frequent and represent in some series more than
90% of whole stones [14e17]. To date there is no longitu-
dinal study speciﬁcally dedicated to Randall’s plaque-
related stones. Several limitations make it difﬁcult to
perform such studies. Actually, few laboratories are able to
detect and analyse the tiny calciﬁcations within umbilica-
tion evidencing thereby that stones result from Randall’s
plaque. Moreover, the increased use of fragmentation
techniques such as shockwaves, ultrasounds or laserpromotes the loss of Randall’s plaque fragments ﬁxed to the
stone. It becomes thereby impossible to identify the renal
origin of these fragmented stones. However, the concomi-
tant increased proportion of Randall’s plaque related intact
stones suggested by some series and the observation that
young patients and children expelled more and more
frequently Randall’s plaque-related stones during the past
years make us prompt to hypothesize that Randall’s plaque
could explain in part the increased incidence of calcium
oxalate stones [12]. There is therefore a need to assess
which environmental factors may affect the urine compo-
sition and would affect Randall’s plaque formation.
3.2. Which are Randall’s plaque biological determinants?
Kuo et al. have shown that hypercalciuria, low diuresis
and low pH correlated with the presence of Randall’s pla-
que in renal stone formers [26]. Worcester et al. accumu-
lated further lines of evidence that Randall’s plaque growth
was related to increased calcium concentration in distal
tubular ﬂuid, promoting calcium-phosphate supersatura-
tion and precipitation [27]. Interestingly, Vermooten
examined 1060 pairs of kidneys in South Africa during the
middle of the past century [4]. He identiﬁed Randall’s
plaques in 17.2% of Caucasians and only in 4.3% of Bantus,
the local native Africans, who are known to have lower
calciuria and to be less affected by calcium-related stones.
Hypercalciuria would therefore be responsible for a
two-step process: Randall’s plaque formation and calcium
oxalate stone formation once plaque has eroded the uro-
thelium. The two main dietary determinants of hyper-
calciuria are salt and protein intakes [28]. As a
consequence, our modern lifestyle and inappropriate diet
enriched with fat, proteins and salt may theoretically
favour Randall’s plaque formation and calcium oxalate
stones as well. In addition, the widespread use of vitamin D
supplementation in children during the past decades,
especially in the USA but also in Europe raises some
questions. Actually, some studies highlighted a relationship
between vitamin D intakes and stone formation [29].
Further studies are required to analyze the diet, vitamin
D intakes and serum levels, and urine composition in renal
stone formers affected by Randall’s plaque.
3.3. What are Randall’s plaque and related stones made of?
Alexander Randall identiﬁed that plaques were made of
calcium phosphate and subsequent studies reported pla-
ques made of hydroxyapatite. Evan et al. described plaques
made of apatite and amorphous calcium phosphate (ACP)
deposits at the surface of the plaque in contact with urine
[25]. Nevertheless, ACP formation is favoured by high CaP
supersaturation and may occur in the interstitium. ACP is
more important in Randall’s plaque than at its surface,
advocating that ACP is the ﬁrst mineral phase generated,
evolving secondarily toward the more stable apatite crys-
talline phase [30]. Of notice, plaques are formed in the
interstitium at physiological pH and apatite is highly
carbonated, resulting in carbapatite rather than hydroxy-
apatite. The morphologic examination of the renal stone
surface combined with Fourier transform infrared
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crystalline phases in Randall’s plaques [31]. Although
Randall’s plaque is made of carbapatite in most cases, and
identiﬁed in more than 97% of plaques in our experience,
other calcium phosphates such as ACP, brushite or whit-
lockite, and other chemical species have been identiﬁed
within Randall’s plaque [31,32]. Compounds such as pu-
rines, particularly sodium urate, are not exceptional and
raise questions about Randall’s plaque formation
mechanisms.
Interestingly, the ﬁrst layers of the stone surrounding
Randall’s plaque are most often made of calcium oxalate
monohydrate [32,33]. Calcium oxalate dihydrate and other
crystalline phases may be present in Randall’s plaque
related stones but not in direct contact with the plaque. The
mechanisms underlying the speciﬁc afﬁnity of calcium
oxalate monohydrate for the plaque remain unknown
(Fig. 3).3.4. Does Randall’s plaque induce renal lesions and
inﬂammatory processes?
Kim et al. have reported than stone episodes were
proportional to the coverage of papilla by Randall’s plaques,
suggesting a high risk of recurrence in these patients [34].
However, whether patients with Randall’s plaque have a
more severe renal prognosis than other renal stone formersFig. 3. Scanning electron microscopy of the interface between Randall’s
plaque made of apatite (foreground) and stone made of monohydrate cal-
cium oxalate (background).is unknown. Although the observation of massive plaques
during reno-ureteroscopies is impressive, the evolution
toward renal failure seems unlikely in most of the cases but
data are missing to draw any conclusion.
The question whether Randall’s plaque may induce the
inﬂammatory process in kidney tissues, and thereby
chronic lesions and ﬁbrosis, is a matter of debate [35].
Further studies based upon human papillary biopsies are
required. Several lines of evidence suggest that Randall’s
plaque may be associated with inﬂammation. The possible
relationship between trace elements and the formation of
the plaque has been obtained through m-X-ray ﬂuorescence
and m-X-ray diffraction [36]. These techniques allowed the
identiﬁcation of dramatic amounts of zinc in carbapatite of
plaques in comparison to carbapatite in kidney stones. Zinc
could be in such a context a biomarker of inﬂammation. In
addition, we observed the presence of macrophages around
some plaques but not in all kidney papillary biopsies (un-
published data). Finally, the presence of urate in some
plaques could promote the NLRP3 inﬂammasome and
activate innate immunity [37,38]. The relationships be-
tween plaque composition and inﬂammatory processes
deserve further studies.
4. Conclusion
Calcium oxalate stone incidence has increased world-
wide during the past decades and the observation that a
large, and probably growing, number of these stones are
related to Randall’s plaque is a warning signal for the
medical community. The environmental determinants and
the pathophysiological mechanisms responsible for Ran-
dall’s plaque formation remain elusive. There is therefore a
need for further clinical studies in patients affected by
Randall’s plaque related stones and for new studies based
upon histopathology. The application of FTIR, m-X-ray
ﬂuorescence and m-X-ray to Randall’s plaque and kidney
tissues allowing in-depth characterization of these plaques
is a ﬁrst step toward the identiﬁcation of the underlying
process at work. Investigatingmore in detail the interaction
between cells and Randall’s plaque is another way to un-
derstand the mechanisms involved in such a lithogenic
process, the occurrence of which has dramatically
increased over the past decades in most of the industrial-
ized countries.
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